The NORD Corporate Council is composed of a select group of leading companies committed to helping people with rare diseases. Members include pharmaceutical, biotech and medical device companies that are developing or marketing therapeutic or diagnostic products, as well as companies that are engaged in other aspects of healthcare for the rare disease/orphan product community such as specialty pharmacies, distributors, contract research organizations, integrated healthcare systems and consulting firms.
Membership on the Council demonstrates a commitment to the identification, diagnosis, treatment and cure of rare disorders through programs of education, advocacy, research and service. The Council provides unique opportunities for companies to engage with experts in the rare disease community, not only with patient advocacy organizations that constitute NORD’s members, but also with top scientific, clinical and policy experts and leaders in the worldwide rare disease community.
Specific benefits for Pre-Clinical Development, Clinical Development, and Approved Product Members include:
Special Benefits for Health Care Business Members Include:
NORD sponsors two annual meetings and on-going teleconferences. The major areas of focus are policy and regulation, patient access and reimbursement, and research and intelligence. View events >
All companies who join the Council must adhere to the Code of Conduct outlining NORD’s interactions with its corporate members. More >
For more information about the Corporate Council, email firstname.lastname@example.org.